VistaGen gobbles up $1M for stem-cell research
South San Francisco-based biotech firm VistaGen Therapeutics raised $1 million in grant funding from the California Institute for Regenerative Medicine (CIRM) to distribute to researchers and other companies working on stem-cell projects linked to diabetes and neurological disorders, reports VentureWire.
VistaGen has raised about $18 million to date, reports VentureWire — including a $3.75 million bridge round snapped up in August. At the time, it dropped the possibility of seeking a $20 million fourth round of funding.
Next Story: 20 seasons in, The Simpsons lands on iTunes
Previous Story: JackBe closes $5M for enterprise mashup apps
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.